Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20063342HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020742HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20069226HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20069227HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020743HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20015002HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20015003HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20021968HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020584HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20022100HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TCGA Plot Options
Drug Information
GeneCD274
DrugBank IDDB00313
Drug NameValproic acid
Target IDBE0003441
UniProt IDQ9NZQ7
Regulation Typedownregulator
PubMed IDs28812434
CitationsBooth L, Roberts JL, Poklepovic A, Dent P: [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells. Cancer Biol Ther. 2017 Sep 2;18(9):705-714. doi: 10.1080/15384047.2017.1362511.
GroupsApproved; Investigational
Direct ClassificationMethyl-branched fatty acids
SMILESCCCC(CCC)C(O)=O
PathwaysValproic Acid Metabolism Pathway
PharmGKBPA451846
ChEMBLCHEMBL109